Table 1.
Age/sex | Relevant comorbidities | Immunosuppression | Antimicrobial prophylaxis | Diagnosis | Species | Diagnostic methods | Negative fungal diagnostics | Peak BDG level | Potential BDG confounders | Outcome | Reference |
---|---|---|---|---|---|---|---|---|---|---|---|
65/F | Autoimmune hemolytic anemia | Not reported | None | CNS | Nocardia abscessus | Histopathology, 16S ribosomal DNA sequencing | Serum cryptococcal antigen, serum galactomannan level, fungal CSF culture | >523 pg/mL (CSF); serum BDG negative | None | Not reported | [10] |
86/F | Colorectal cancer, diabetes mellitus | 6-month dexamethasone (4 mg/day) course | None | Pulmonary | Nocardia nova | Cytology, 16S rRNA sequencing | Aspergillus antigen, Aspergillus precipitating antibody, fungal sputum culture | ≥300 pg/mL | None | Clinical improvement then death from underlying malignancy | [11] |
73/M | Cryptogenic organizing pneumonia | 10-month steroid and immunosuppressive regimen | None | Disseminated (pulmonary and CNS) | Nocardia farcinica | Histopathology, 16S rRNA sequencing | Serum cryptococcal antigen | 94.7 pg/mL | Intravenous ampicillin-sulbactam use, serum galactomannan level elevated | Clinical improvement then death from aspiration pneumonia | [12] |
Abbreviations: BDG, beta-D-glucan; CNS, central nervous system; CSF, cerebrospinal fluid; DNA, deoxyribonucleic acid; rRNA, ribosomal ribonucleic acid.